Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22847
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSTEVENS, An-Sofie-
dc.contributor.authorPIROTTE, Nicky-
dc.contributor.authorWOUTERS, Annelies-
dc.contributor.authorVAN ROTEN, Andromeda-
dc.contributor.authorVAN BELLEGHEM, Frank-
dc.contributor.authorWILLEMS, Maxime-
dc.contributor.authorCUYPERS, Ann-
dc.contributor.authorARTOIS, Tom-
dc.contributor.authorSMEETS, Karen-
dc.date.accessioned2016-12-02T14:50:22Z-
dc.date.available2016-12-02T14:50:22Z-
dc.date.issued2016-
dc.identifier.citationCURRENT DRUG TARGETS, 17(12), p. 1414-1437-
dc.identifier.issn1389-4501-
dc.identifier.urihttp://hdl.handle.net/1942/22847-
dc.description.abstractA delicate balance exists between the process of carcinogenesis and tissue regeneration. A number of malignant tumours are considered the outcome of an impaired or incomplete regeneration process, resulting in persistently dividing cells. Regeneration-competent tissues and animals are able to prevent and counteract growth abnormalities and seem to have a low vulnerability to chemical carcinogenesis. Cancer cell survival depends, among other things, on various redox-related mechanisms, which are targets of currently developed therapies. Disadvantages of these therapies are a lack of specificity and drug resistance. As the majority of these redox-related mechanisms also play an important role in successful and coordinated cell functioning and reproduction, the regeneration process offers a unique parallel context for modern cancer research. This review focuses on the interconnections between regeneration and carcinogenesis and how an understanding of regenerative forces and redox-controlled mechanisms could contribute to the identification of new therapeutic targets to block the growth and survival of cancer cells.-
dc.description.sponsorshipThis work was supported by the Bijzonder OnderzoeksFonds of Hasselt University (BOF08G01) and Hasselt University tUL-impulsfinanciering (project toxicology). The work of An-Sofie Stevens was financed by a PhD grant for An-Sofie Stevens from IWT (Agentschap voor Innovatie door Wetenschap en Technologie) (no. 101442). Maxime Willems was funded by an OZM grant by IWT (no. 100631).-
dc.language.isoen-
dc.publisherBENTHAM SCIENCE PUBL LTD-
dc.subject.otheranticarcinogenic therapies; carcinogenesis; redox-related mechanisms; regeneration; stem cells-
dc.subject.otherAnticarcinogenic therapies; carcinogenesis; redox-related mechanisms; regeneration; stem cells-
dc.titleRedox-Related Mechanisms to Rebalance Cancer-Deregulated Cell Growth-
dc.typeJournal Contribution-
dc.identifier.epage1437-
dc.identifier.issue12-
dc.identifier.spage1414-
dc.identifier.volume17-
local.format.pages24-
local.bibliographicCitation.jcatA1-
dc.description.notes[Stevens, An-Sofie; Pirotte, Nicky; Wouters, Annelies; Van Roten, Andromeda; Van Belleghem, Frank; Cuypers, Ann; Artois, Tom; Smeets, Karen] Hasselt Univ, Ctr Environm Sci, Agoralaan,Bldg D, B-3590 Diepenbeek, Belgium. [Van Belleghem, Frank] Open Univ, Fac Management Sci & Technol, Valkenburgweg 177, Heerlen, Netherlands;. [Willems, Maxime] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Technol, B-9000 Ghent, Belgium. [Willems, Maxime] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, Jozef Plateaustr 22, B-9000 Ghent, Belgium.-
local.publisher.placeSHARJAH-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.identifier.doi10.2174/1389450116666150506112817-
dc.identifier.isi000387082600006-
item.validationecoom 2017-
item.contributorSTEVENS, An-Sofie-
item.contributorPIROTTE, Nicky-
item.contributorWOUTERS, Annelies-
item.contributorVAN ROTEN, Andromeda-
item.contributorVAN BELLEGHEM, Frank-
item.contributorWILLEMS, Maxime-
item.contributorCUYPERS, Ann-
item.contributorARTOIS, Tom-
item.contributorSMEETS, Karen-
item.fullcitationSTEVENS, An-Sofie; PIROTTE, Nicky; WOUTERS, Annelies; VAN ROTEN, Andromeda; VAN BELLEGHEM, Frank; WILLEMS, Maxime; CUYPERS, Ann; ARTOIS, Tom & SMEETS, Karen (2016) Redox-Related Mechanisms to Rebalance Cancer-Deregulated Cell Growth. In: CURRENT DRUG TARGETS, 17(12), p. 1414-1437.-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.issn1389-4501-
crisitem.journal.eissn1873-5592-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Redoxrelatedmechanisms.pdfPeer-reviewed author version883.96 kBAdobe PDFView/Open
Stevens(2016).pdf
  Restricted Access
Published version12.52 MBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.